A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The metric has seen a significant loss of -53.52% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -46.83%. Over the past 30 days, the price of PPBT has leaped by -18.05%. And in the last five days, it has fallen by -18.43%.
Purple Biotech Ltd ADR ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $20.60 on 05/31/24, while the lowest value for the same period was recorded at $2.00 on 11/22/24.
52-week price history of PPBT Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Purple Biotech Ltd ADR’s current trading price is -89.42% away from its 52-week high, while its distance from the 52-week low is 9.00%. The stock’s price range during this period has varied between$2.00 and $20.60. The Purple Biotech Ltd ADR’s shares, which operate in the Healthcare, saw a trading volume of around 4.08 million for the day, a figure considerably higher than their average daily volume of 25620.0 over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Purple Biotech Ltd ADR (PPBT) has experienced a quarterly decline of -35.12% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 5.78M and boasts a workforce of 9 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 3.23, with a change in price of -3.95. Similarly, Purple Biotech Ltd ADR recorded 115,081 in trading volume during the last 100 days, posting a change of -60.12%.
PPBT’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for PPBT stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.00.
PPBT Stock Stochastic Average
Purple Biotech Ltd ADR’s raw stochastic average for the past 50 days is presently 27.22%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 50.00%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 46.91% and 53.15%, respectively.
